NovaBridge Biosciences: revenue
| Value | {"unit": "CNY", "value": 88026000, "concept": "us-gaap:Revenues"} |
|---|---|
| Period | 2021-01-01 – 2021-12-31 |
| Status | current |
| Entity | NovaBridge Biosciences |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:00:43.919806+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/702701eb-da3a-48d4-a1f2-6c77c1584562
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001104659-23-053462Retrieved: 2026-08-19T18:00:43.919806+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001778016/revenue/2021-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/702701eb-da3a-48d4-a1f2-6c77c1584562
History
- supersedes {"amount": 13813000, "concept": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "currency": "USD"} (evidence 0001193125-22-133550)